Diabetes Monitoring and Diagnosis Beyond A1c
A recently published review article in Diabetes Care investigated various glycated proteins that can be used for diabetes diagnosis and management. The study concluded that fructosamine, glycated albumin, and advanced end products (AGEs) can be used for assessment and treatment where traditional HbA1c testing is limited. The authors predict that the “newer measures of glycated proteins will [not] be studied” as thoroughly as HbA1c “because of limited funding.” The article proposes development of “innovative strategies to establish the evidence base for the link between other glycated proteins and clinical outcomes, so that treatment targets or diagnostic thresholds can be developed.”
Corporate Communications Associate
Epinex Diagnostics, Inc.